As of June 11, 2024, Deciphera is now a member of ONO Pharma. To learn more about ONO Pharma,
click here.
One Mission, Inspired by Patients:
Defeat Cancer.™
In the past three decades, tremendous progress has been made in the fight against cancer, but there is still so much more work to be done. At Deciphera, we remain steadfast in our mission to improve the lives of people living with cancer - and that passion for making a difference extends to the patient groups and communities in which we live and work.
A targeted approach with extraordinary potential
Kinases are enzymes that help regulate cellular function. When they do not work properly, these enzymes contribute to the growth and spread of many cancers. We design switch-control kinase inhibitors with the goal of potentially improving patient responses to treatment and, ultimately, patient outcomes.
Inspired by patients, driven by science
We come to work every day with a sustained commitment to improving human health - it’s what pushes us to innovate. At Deciphera, we are united in our goal to defeat cancer.
We are impacting the lives of people living with cancer by addressing key mechanisms of tumor and drug resistance that limit the results of some existing therapies. We have developed a diverse pipeline of drug candidates with the aim of making a difference in patients’ lives.
Discover "The Deciphera Difference"
